Patent details

91104 Product Name: Everolimus et ses dérivés pharmaceutiquement acceptables (CERTICAN®)

Basic Information

Publication number:
91104
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP939208229
Legal Status:
Expired
Application number:
91104
First applicant's nationality:
Procedural language:
French

Paediatric Extension

SPC Extension Filing Date:
06/07/2016
SPC Extension Agent Name:
OFFICE FREYLINGER S.A.
SPC Extension Status:
Granted
SPC Extension Grant Date:
29/12/2017
SPC Extension Rejection Date:

Marketing Authorization

1

Marketing Authorization Number:
0135/04/03/0105-0110
Marketing Authorization Type:
Marketing Authorization Date:
02/04/2004
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

2

Marketing Authorization Number:
18690-95
Marketing Authorization Type:
Marketing Authorization Date:
18/07/2003
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Sweden (SE)

Dates

Filing date:
29/09/2004
First Marketing Authorization date:
18/07/2003
Grant date:
29/11/2004
Activation date:
24/09/2013
Publication date:
29/11/2004
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
18/07/2018
SPC Extension Expiration:
18/01/2019
Rejection date:
Withdrawal date:

Owner

From:
13/03/2019
 
 

Name:
NOVARTIS INTERNATIONAL PHARMACEUTICAL AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)

Name:
NOVARTIS PHARMA AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)

History of Owners

From:
29/09/2004
To:
13/03/2019

Name:
NOVARTIS AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Agent

1

Name:
OFFICE FREYLINGER S.A.
From:
29/12/2017
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

2

Name:
ERNEST T. FREYLINGER,ARMAND SCHMITT, PIERRE KIHN, J. BEISSEL, R. LAMBERT, P. OCVIRK, O. LAIDEBEUR
From:
29/09/2004
Address:
ROUTE D'ARLON 234, 8001, STRASSEN, Luxembourg (LU)
To:
29/12/2017

Inventor

1

Name:
COTTENS Sylvain
Address:
Switzerland (CH)

2

Name:
SEDRANI Richard
Address:
Switzerland (CH)

Licencee

Name:
N.V. Novartis Pharma S.A.
From:
27/03/2019
Address:
Medialaan 40, 1800, Vilvoorde, Belgium (BE)
To:

Publication

Bulletin

1

Bulletin Heading:
CO
Bulletin edition number:
2019/05
Publication date:
11/04/2019
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:
MED
Bulletin edition number:
2019/06
Publication date:
06/05/2019
Description:
Section K : Modifications and recordals into the register

3

Bulletin Heading:
SPCX1
Bulletin edition number:
2017/02
Publication date:
22/06/2017
Description:
Section G : Applications for extensions for pediatric use – I1E publication

4

Bulletin Heading:
SPCX1
Bulletin edition number:
2018/02
Publication date:
15/01/2018
Description:
Section G : Applications for extensions for pediatric use – I1E publication

5

Bulletin Heading:
SPCX2
Bulletin edition number:
2018/02
Publication date:
15/01/2018
Description:
Section H : Granted extensions for pediatric use of supplementary protection certificates – I2E publication

6

Bulletin Heading:
SPCX2
Bulletin edition number:
2018/02
Publication date:
15/01/2018
Description:
Section H : Granted extensions for pediatric use of supplementary protection certificates – I2E publication

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20190000121A
Date Registered:
13/03/2019
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

1

Name:
NOVARTIS PHARMA AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)

2

Name:
NOVARTIS INTERNATIONAL PHARMACEUTICAL AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)

Removed Pledgee

Name:
Address:

Licence

Change Kind/ Decision Type:
New licence registration
Deed Number:
RC20190000139C
Date Registered:
27/03/2019
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Not Exclusive
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Country Code:
Luxembourg (LU)
Updated Licence Number:
Terminated Licence Number:

Added Licencee(s)

Name:
N.V. Novartis Pharma S.A.
Address:
Medialaan 40, 1800, Vilvoorde, Belgium (BE)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
20/09/2017
Last Annual Fee Paid Number:
25
Last Annual Fee Paid Amount:
450 Euro
Payer:
MARKS & CLERK LLP